
Financials · Financial Exchanges & Data
$608.87
+4.56%
Vol: 37K
Monday, June 15, 2026
No material news in the last 48 hours.
No material news in the last 48 hours.
MSCI announced May 2026 Index Review results on May 12, 2026, implementing changes at close of May 29. Forty-nine securities added and 101 deleted from MSCI ACWI Index. Largest World Index additions: Medline A, MasTec, TechnipFMC. Largest EM additions: Itau Unibanco, Yangtze Optical Fibre, Sichuan Biokin. Small Cap: 246 adds, 195 deletes. Greece to be reclassified from EM to Developed Market in May 2027. Dividend of $2.05/share payable May 29. Acquired PM Insights for private markets data.
MSCI announced results of its May 2026 Equity Index Review on May 12, with 49 securities added and 101 deleted from the MSCI ACWI Index, including new additions Medline, MasTec and TechnipFMC to the World Index; changes take effect at the close of May 29. The Emerging Markets Index adds Itau Unibanco, Yangtze Optical Fibre and Sichuan Biokin Pharmaceutical, while 246 names enter and 195 exit the ACWI Small Cap Index. MSCI also announced it will reclassify the MSCI Greece Indexes from Emerging to Developed Market status at the May 2027 review. Separately, MSCI disclosed the acquisition of PM Insights, a private markets data and analytics specialist covering an estimated $5.5T in private company equity market value. Shares eased ~1.75% in the short term but show a 9.32% 90-day return. Risks: ongoing fee-pressure narrative in index/data and integration risk for the PM Insights deal.
On May 12, 2026, MSCI announced the May 2026 Index Review results effective close of May 29. MSCI ACWI Index adds 49 securities and deletes 101; largest World additions: Medline A, MasTec, TechnipFMC. Largest EM additions: Itau Unibanco, Yangtze Optical Fibre, Sichuan Biokin. ACWI Small Cap adds 246 / deletes 195. MSCI Greece Indexes to be reclassified from EM to DM in single step at May 2027 Index Review. Frontier Markets adds five securities. Bear case: 1-day return -1.75% and 7-day -1.93%; high-multiple data stock vulnerable to rate moves.
No material news in the last 48 hours. The most recent material event was the May 12, 2026 May Index Review announcement.
MSCI Inc. delivered Q1 2026 revenue of $850.8M, up 14.1% YoY, driven by record subscription growth and AI integration; EPS rose 11.7% YoY. The company is going ex-dividend soon with a $2.05/share quarterly payout, continuing a 10-year average annual dividend increase of 25%. MSCI also acquired PM Insights to expand its objective pricing and valuation data offerings. Analyst consensus is Strong Buy with a 12-month PT of $682.44 (~14% upside from $570.91 close on 5/13). Risk: rich 33x P/E leaves limited cushion if subscription growth decelerates or active fund outflows accelerate.
On May 12, 2026 MSCI announced the results of its May 2026 Equity Index Review, with all changes implemented at the close of May 29. Forty-nine securities were added to and 101 deleted from the MSCI ACWI Index; the three largest World Index additions were Medline A, MasTec and TechnipFMC. MSCI Greece will be reclassified from Emerging to Developed Market status in one step coinciding with the May 2027 review. CGS International estimates roughly $1.8B in passive outflows tied to the Indonesia rebalancing. MSCI also acquired PM Insights, a private markets data and analytics firm. Q1 2026 results showed $850.8M in revenue with a $2.05 dividend declared. Risk: passive-flow reversals and ongoing fee compression in index licensing.
On May 12, 2026, MSCI announced the results of its May 2026 Index Review, with 49 securities added and 101 deleted from the MSCI ACWI Index, all changes effective at close of May 29. The largest additions to the MSCI World Index include Medline A, MasTec, and TechnipFMC. MSCI cut Indonesian stocks linked to the country's richest billionaires, including PT Barito Renewables Energy and PT Dian Swastatika Sentosa, after the Indonesia Stock Exchange named them as tightly held. CGS International estimates roughly $1.8 billion of passive outflows tied to the rebalancing. MSCI Greece Indexes will be reclassified from Emerging to Developed Market in May 2027. Shares closed at $583.65 on May 12.
MSCI is scheduled to announce the results of its May 2026 Index Review on May 12 after 11pm CEST; changes take effect at close of May 29, affecting global standard, small cap, frontier markets, and value/growth indexes. Q1 2026 results showed 14.1% revenue growth, 13% organic, ~14% adjusted EPS growth, ~19% adjusted EBITDA growth, with EPS of $4.55 (vs $4.38-$4.40 consensus) and revenue of $850.8M (vs $830.9M est.). Asset-based fees annualized growth rate hit 25% to record $872M. Buybacks of $464M at ~$556/share. Cash dividend of $2.05 declared with May 15 ex-date.
No material news in the last 48 hours.
MSCI delivered strong Q1 2026 with revenue up 14.1% to $850.8 million, net income up 40.7% to $406.0M, and diluted EPS up 49.1% to $5.53. The company announced a 13.9% dividend increase and strategic acquisition of Compass Financial Technologies to expand index capabilities in multi-asset classes including commodities and digital assets. Index review scheduled for May 2026. Analyst upgrades from Raymond James (target $730 from $700) reflect momentum. Barclays maintained Buy rating.
MSCI delivered robust Q1 2026 results with revenues reaching $850.8M (+14.1% YoY), net income surging 40.7% to $406M, and diluted EPS jumping 49.1% to $5.53. The company announced a 13.9% dividend increase. Strategic acquisitions: Compass Financial Technologies expands index calculation across multi-asset and alternative classes including commodities and cryptocurrencies; PM Insights acquisition enhances objective pricing and valuation data. Barclays maintains Buy; Argus Research issues Buy; Raymond James raises PT to $730 from $700.
MSCI reported strong Q1 2026 financial results with operating revenues of $850.8M (+14.1%), net income of $406.0M (+40.7%), and diluted EPS of $5.53 (+49.1%). The company acquired Compass Financial Technologies to expand index calculation capabilities across multi-asset and alternative classes including commodities and cryptocurrencies. MSCI also acquired PM Insights for objective pricing and valuation data. Management will speak at Barclays and Bernstein investor conferences in May. Record subscription growth and AI integration drove the strong quarter. Stock trades at $583 with P/E of 33.25.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| MSCIMSCI | $608.87 | +4.56% | -0.3% | 25.9x | 1.24 | $42.4B |
| SPGIS+P | $426.74 | +2.65% | -0.4% | 18.7x | 1.10 | $123.1B |
| CMECME | $269.19 | -6.95% | -5.2% | 22.4x | 0.26 | $104.8B |
| ICEINTERCONTINENTAL | $141.93 | -6.31% | -2.9% | 17.3x | 0.96 | $85.7B |
| MCOMOODY | $457.31 | +2.68% | +0.4% | 23.9x | 1.37 | $77.8B |
| NDAQNASDAQ | $91.34 | +1.02% | -2.4% | 20.4x | 0.99 | $51.1B |
Price above both MAs — bullish structure.